en

PRODUCT DETAIL

Pandemic influenza vaccine H5N1 AstraZeneca nosová suspenzná aerodisperzia

Code 9794B
MA number EU/1/16/1089/001
Product Form: aer nau 10x0,2 ml (apli.nos.skl.)
MA Status: Ex - Conditional centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
J ANTIINFECTIVES FOR SYSTEMIC USE
J07 VACCINES
J07B VIRAL VACCINES
J07BB Influenza vaccines
J07BB03 Influenza, live attenuated
Shelf life: 18 týždňov
Container: nasal applicator
Route of admin.: Nasal use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 20.05.2016
Validity: 24.05.2022
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 16.03.2021
eu-flag.png sk-flag.png